• Entry
  • Reader's guide
  • Entries A-Z
  • Subject index

Rimonabant is the first inverse agonist discovered for the cannabinoid-1 receptor (CB1R) and is being developed for the treatment of obesity. Although rimonabant binds to the CB1R, it is ...

    • Loading...
    locked icon

    Sign in to access this content

    Get a 30 day FREE TRIAL

    • Watch videos from a variety of sources bringing classroom topics to life
    • Read modern, diverse business cases
    • Explore hundreds of books and reference titles